Search for Clinical Trial Results
Gliosarcoma - 27 Studies Found
Status | Study |
Recruiting |
Study Name: Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Condition:
Date: 2014-12-08 Interventions:
|
Completed |
Study Name: Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme Condition:
Date: 2009-09-15 Interventions:
|
Completed |
Study Name: Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors Condition:
Date: 2005-09-13 Interventions:
|
Completed |
Study Name: Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Condition:
|
Active, not recruiting |
Study Name: Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma Condition:
|
Completed |
Study Name: Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma Condition:
|
Completed |
Study Name: Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Condition:
|
Completed |
Study Name: Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Condition:
|
Terminated |
Study Name: Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Condition: Adult Brain Tumors Date: 2006-10-12 Interventions: Drug: erlotinib hydrochloride Tarceva will be self-administered in an open-label, unblinded manner to al |
Enrolling by invitation |
Study Name: Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 Condition: Glioblastoma Date: 2015-04-23 Interventions:
|